Regional Assessment of Brain Atrophy: A Novel Approach to Achieve a More Complete Picture of Tissue Damage Associated with Central Nervous System Disorders?

References

1. ↵
   Ramani A, Jensen JH, Helpern JA. Quantitative MR imaging in Alzheimer disease. Radiology 2006;241:26–44

   CrossRefPubMedWeb of Science
2. ↵
   Miller DH, Barkhof F, Frank JA, et al. Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 2002;125:1676–95

   Abstract/FREE Full Text
3. ↵
   Good CD, Johnsrude IS, Ashburner J, et al. A voxel-based morphometric study of ageing in 465 normal adult human brains. NeuroImage 2001;14:21–36

   CrossRefPubMedWeb of Science
4. ↵
   Masdeu JC, Zubieta JL, Arbizu J. Neuroimaging as a marker of the onset and progression of Alzheimer’s disease. Neurol Sci 2005;236:55–64
5. ↵
   Bozzali M, Filippi M, Magnani G, et al. The contribution of voxel-based morphometry in staging patients with mild cognitive impairment. Neurology 2006;67:453–60

   Abstract/FREE Full Text
6. ↵
   Mezzapesa DM, Ceccarelli A, Dicuonzo F, et al. Whole-brain and regional brain atrophy in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol 2007;28:255–59

   Abstract/FREE Full Text
7. ↵
   Chang JL, Lomen-Hoerth C, Murphy J, et al. A voxel-based morphometry study of patterns of brain atrophy in ALS and ALS/FTLD. Neurology 2005;65:75–80

   Abstract/FREE Full Text
8. ↵
   Ince PG. Amyotrophic lateral sclerosis. In: Brown RH, Meininger V, Swash M, eds. Neuropathology. London: Martin Dunitz;2000 :83–112